{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:04:29Z","timestamp":1789657469046,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":1309,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.nrl.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T00:26:00Z","timestamp":1342311960000},"page":"276-282","source":"Crossref","is-referenced-by-count":11,"title":["Utilidad de la tomograf\u00eda por emisi\u00f3n de fot\u00f3n simple con 123Ioflupano en el diagn\u00f3stico del parkinsonismo relacionado con f\u00e1rmacos. Estudio prospectivo"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Olivares Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Arjona Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2012.05.005_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","article-title":"Drug induced parkinsonism: a common cause of parkinsonism in older people","volume":"85","author":"Thanvi","year":"2009","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.nrl.2012.05.005_bib0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.5.6.759","article-title":"Drug-induced parkinsonism","volume":"5","author":"Mena","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nrl.2012.05.005_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clineuro.2010.03.003","article-title":"The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics","volume":"112","author":"Munhoz","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nrl.2012.05.005_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: incidence, management and prevention","volume":"29","author":"L\u00f3pez-Send\u00f3n","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2012.05.005_bib0025","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug-induced parkinsonism: A review of 17 years\u2019 experience in a regional pharmacovigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002512-199405020-00006","article-title":"Drug-induced parkinsonism in the aged. Recognition and prevention","volume":"5","author":"Gershanik","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2012.05.005_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2515\/therapie:2004021","article-title":"Drug-induced Parkinson syndromes","volume":"59","author":"Nguyen","year":"2004","journal-title":"Therapie"},{"key":"10.1016\/j.nrl.2012.05.005_bib0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/MNM.0b013e328338456e","article-title":"SPECT FP-CIT. in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up","volume":"31","author":"Hamb\u00ffe","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nrl.2012.05.005_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.amjopharm.2011.09.002","article-title":"Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature","volume":"9","author":"Mahmoud","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.nrl.2012.05.005_bib0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mds.21188","article-title":"Valproate-induced Parkinsonism in epilepsy patients","volume":"22","author":"Jamora","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0055","first-page":"22","article-title":"A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients","volume":"57","author":"Ghadirian","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.005_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2515\/therapie:2005061","article-title":"Trimetazidine induces parkinsonism, gait disorders and tremor","volume":"60","author":"Mart\u00ed Mass\u00f3","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.nrl.2012.05.005_bib0165","unstructured":"Shannon KM. Trastornos del movimiento. En: Bradley, W.G., Daroff, R.B., Fenichel, G.M., Jankovic, J., editores., Neurolog\u00eda, cl\u00ednica., IV, ed., Madrid, 2004. p. 2105\u201352."},{"key":"10.1016\/j.nrl.2012.05.005_bib0070","first-page":"757","article-title":"Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance","volume":"150","author":"Llau","year":"1994","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nrl.2012.05.005_bib0075","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(84)91516-2","article-title":"Drug-induced parkinsonism in the elderly","volume":"2","author":"Stephen","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2012.05.005_bib0080","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/mds.22805","article-title":"Levosulpiride-induced movement disorders","volume":"24","author":"Shin","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00415-009-5039-0","article-title":"Clinical and [123I]FP-CIT SPECT imaging follow-up in patients with drug-induced parkinsonism","volume":"256","author":"Tinazzi","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2012.05.005_bib0090","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00259-009-1289-4","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease","volume":"37","author":"D\u00edaz-Corrales","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nrl.2012.05.005_bib0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.21854","article-title":"Failure of recognition of drug-induced parkinsonism in the elderly","volume":"23","author":"Esper","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"K\u00e4gi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.005_bib0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","article-title":"Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes","volume":"59","author":"Vlaar","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nrl.2012.05.005_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0025-7753(04)74224-4","article-title":"Differential diagnosis of parkinsonism using dopamine transporters brain SPECT","volume":"122","author":"Lorenzo Bosquet","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.nrl.2012.05.005_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(00)00023-2","article-title":"Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT","volume":"47","author":"Lavalaye","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.nrl.2012.05.005_bib0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"Suppl. 7","key":"10.1016\/j.nrl.2012.05.005_bib0130","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/mds.10575","article-title":"DAT imaging in drug-induced and psychogenic parkinsonism","volume":"18","author":"Tolosa","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0135","first-page":"1224","article-title":"(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis","volume":"6","author":"Jennings","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2012.05.005_bib0140","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.npp.1300683","article-title":"Validation of 123I beta CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram","volume":"30","author":"Win de","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nrl.2012.05.005_bib0145","first-page":"359","article-title":"Quantification of striatal dopamine transporters with 123 I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects","volume":"48","author":"Booij","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nrl.2012.05.005_bib0150","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.22098","article-title":"[123I] FP-CIT SPET imaging in drug-induced Parkinsonism","volume":"23","author":"Tinazzi","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.005_bib0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","article-title":"Increased risk of Parkinson's disease after depression: a retrospective cohort study","volume":"58","author":"Schuurman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.05.005_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: a register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Mov Disord"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312001867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312001867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T06:13:41Z","timestamp":1642745621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485312001867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0213485312001867"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2012.05.005","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}